During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky.

The Biologics Price Competition and Innovation Act of 2009 created the abbreviated approval pathway that biosimilars rely on, and the FDA has approved 82 biosimilars to date, with the new guidance is ...

The leadership changes arrive as BioNTech reported a 57% rise in net losses for 2025.

No matter how hard this is, I still recommend clinical trials. Not as a last resort, but as an important option when weighing treatment choices. I don’t know what choice I’ll make, but I’m thankful ...

Redwire RDW shares are up on Wednesday as the company has secured additional funding from NASA. This positive movement comes amid a mixed market day, with major indices showing varied performance. • ...

The AI in precision medicine market shows strong growth prospects driven by the need for personalized therapies amid rising chronic diseases. Key opportunities include advancements in AI for ...

The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at ...

Glo-BNHL global trial opens sites in Netherlands and Austria to trial multiple new treatments for B-cell Non-Hodgkin Lymphoma ...

Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred herein as 'Ascentage Pharma,” the 'Company,” 'we,” 'us” or 'our”), a global, commercial stage, integrated ...

The Citizens Life Sciences Conference 2026 March 11, 2026 9:35 AM EDTCompany ParticipantsAndrew Peters - Senior Vice President ...

The Citizens Life Sciences Conference 2026 March 11, 2026 10:45 AM EDTCompany ParticipantsHelen Torley - President, ...

YCANTH® net revenue grew 130% to $15.3 million in 2025, and selling, general and administrative expenses decreased by over 40%, when compared to 2024 - - Company earned $35.6 million in total revenue ...